Cargando…

A nomogram for prediction of stage III/IV gastric cancer outcome after surgery: A multicenter population‐based study

Most patients with gastric cancer (GC) are first diagnosed at stage III‐IV and surgery resection remains the primary therapeutic modality for these patients. However, clinical staging used for prediction of those patients provides limited information. We collected clinicopathological data and diseas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Zhiying, Ni, Jing, Ding, Hui, Yan, Caiwang, Ren, Chuanli, Li, Gang, Pan, Feng, Jin, Guangfu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402842/ https://www.ncbi.nlm.nih.gov/pubmed/32543092 http://dx.doi.org/10.1002/cam4.3215

Ejemplares similares

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

A nomogram to predict the cancer‐specific survival of stage II–IV Epithelial ovarian cancer after bulking surgery and chemotherapy
por: Zhao, Ling, et al.
Publicado: (2021)

Development and validation of a nomogram predicting the overall survival of stage IV breast cancer patients
por: Li, Shunrong, et al.
Publicado: (2017)

Development and validation of nomogram models to predict radiotherapy or chemotherapy benefit in stage III/IV gastric adenocarcinoma with surgery
por: Ren, Xiangqing, et al.
Publicado: (2023)

A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma
por: Kudchadkar, Ragini, et al.
Publicado: (2015)

LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology
por: Garrido, Pilar, et al.
Publicado: (2021)

Additional radiotherapy to breast‐conserving surgery is an optional treatment for de novo stage IV breast cancer: A population‐based analysis
por: Wang, Jun, et al.
Publicado: (2021)

Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
por: Mandalá, Mario, et al.
Publicado: (2021)

Improving survival of stage II‐III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy
por: Li, Yang, et al.
Publicado: (2020)

Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer
por: Bando, Etsuro, et al.
Publicado: (2020)

Current treatment and surveillance modalities are not sufficient for advanced stage III colon cancer: Result from a multicenter cohort analysis
por: Li, Juan, et al.
Publicado: (2021)

Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancer
por: Wang, Yizhuo, et al.
Publicado: (2016)

Conversion surgery for stage IV gastric cancer: a multicenter retrospective study
por: Kano, Yosuke, et al.
Publicado: (2022)

A Predictive Nomogram for Early Mortality in Stage IV Gastric Cancer
por: Feng, Yuqian, et al.
Publicado: (2020)

Developing Preoperative Nomograms to Predict Any-Stage and Stage III-IV Endometriosis in Infertile Women
por: Guo, Zaixin, et al.
Publicado: (2020)

Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population‐based study
por: Shi, Tao, et al.
Publicado: (2019)

EGFR‐mutated stage IV non‐small cell lung cancer: What is the role of radiotherapy combined with TKI?
por: Liu, Bailong, et al.
Publicado: (2021)

Patient‐controlled subcutaneous analgesia using sufentainil or morphine in home care treatment in patients with stage III‐IV cancer: A multi‐center randomized controlled clinical trial
por: Wan, Cheng‐Fu, et al.
Publicado: (2020)

The prediction model of operative link on gastric intestinal metaplasia stage III-IV: A multicenter study
por: Wang, Song, et al.
Publicado: (2023)

Development and validation of pretreatment nomogram for disease‐specific mortality in gastric cancer‐A competing risk analysis
por: Bando, Etsuro, et al.
Publicado: (2021)

A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer
por: Xu, Ke, et al.
Publicado: (2020)

A novel nomogram to predict the local tumor progression after microwave ablation in patients with early‐stage hepatocellular carcinoma: A tool in prediction of successful ablation
por: An, Chao, et al.
Publicado: (2019)

Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer
por: Wang, De‐shen, et al.
Publicado: (2019)

Efficacy of surgery and chemotherapy for stage IV small bowel adenocarcinoma: A population‐based analysis using Surveillance, Epidemiology, and End Result Program database
por: Liu, Tongtong, et al.
Publicado: (2020)

Social determinants of stage IV anal cancer and the impact of pelvic radiotherapy in the metastatic setting
por: Repka, Michael C., et al.
Publicado: (2017)

Development and Validation of Nomograms to Predict Operative Link for Gastritis Assessment Any-Stage and Stages III–IV in the Chinese High-Risk Gastric Cancer Population
por: Wang, Song, et al.
Publicado: (2021)

The prognostic value of circRNAs for gastric cancer: A systematic review and meta‐analysis
por: Chen, Hui, et al.
Publicado: (2020)

Integration of GWAS and eQTL Analysis to Identify Risk Loci and Susceptibility Genes for Gastric Cancer
por: Ni, Jing, et al.
Publicado: (2020)

Development and validation of a nomogram for patients with stage II/III gastric adenocarcinoma after radical surgery
por: Wang, Lei, et al.
Publicado: (2022)

Pathological tumor infiltrative pattern and sites of initial recurrence in stage II/III gastric cancer: Propensity score matching analysis of a multi‐institutional dataset
por: Nakagawa, Nobuhiko, et al.
Publicado: (2018)

The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ–Ⅲ esophageal cancer: a SEER‐based demographic analysis
por: Lv, Hao, et al.
Publicado: (2021)

Commentary on: Nomograms based on inflammatory biomarkers for predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinoma
por: Xiao, Liang, et al.
Publicado: (2019)

Evaluating overall survival and competing risks of survival in patients with early‐stage breast cancer using a comprehensive nomogram
por: Xu, Yan‐Bo, et al.
Publicado: (2020)

New nomograms to predict overall and cancer‐specific survival of angiosarcoma
por: Liu, Yuan‐Yuan, et al.
Publicado: (2021)

Metabolic syndrome predicts postoperative complications after gastrectomy in gastric cancer patients: Development of an individualized usable nomogram and rating model
por: Chen, Xiaodong, et al.
Publicado: (2020)

Patterns of care for older patients with stage IV non‐small cell lung cancer in the immunotherapy era
por: Kehl, Kenneth L., et al.
Publicado: (2020)

Conversion Surgery for Stage IV Gastric Cancer
por: Zhang, Fei, et al.
Publicado: (2019)

Combination of preoperative plasma fibrinogen and AJCC staging improves the accuracy of survival prediction for patients with stage I‐II gastric cancer after curative gastrectomy
por: Ding, Peng, et al.
Publicado: (2019)

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer
por: Karim, Safiya, et al.
Publicado: (2019)

Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database
por: Zhang, Rui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bk7uckbck0jr35r73r4mjnge2k